Valion Bio, Inc.
VBIO
$1.10
-$0.01-0.90%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.85M | -2.60M | -1.93M | -1.50M | -1.48M |
| Total Depreciation and Amortization | 3.00K | 0.00 | 1.00K | 1.00K | 273.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 470.00K | 579.00K | 176.00K | 100.00K | 584.00K |
| Change in Net Operating Assets | -8.00K | 21.00K | -73.00K | 512.00K | -745.00K |
| Cash from Operations | -2.29M | -2.00M | -1.83M | -889.00K | -1.37M |
| Capital Expenditure | -25.00K | -10.00K | -3.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -124.00K | 0.00 | -17.00K | -526.00K | -- |
| Cash from Investing | -149.00K | -10.00K | -20.00K | -526.00K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 429.00K | 1.91M | 109.00K | 1.12M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 11.87M | 3.75M | 585.00K | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -240.00K | 90.00K | -131.00K | -27.00K | 63.00K |
| Cash from Financing | 11.63M | 4.27M | 2.36M | 82.00K | 1.18M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.20M | 2.27M | 515.00K | -1.33M | -187.00K |